AMCP Market Insights Health Plan Best Practice: Implementing continuous glucose monitoring to improve patient outcomes in diabetes

Michael Pangrace,Sheri Dolan,Thomas Grace,Estay Greene,Eric Long,Scott McClelland,Josh Moore,Diane E Morgan,Heather Mullins,Susan Wescott,Diane E. Morgan
DOI: https://doi.org/10.18553/jmcp.2024.30.1-a.s1
2024-01-01
Journal of Managed Care & Specialty Pharmacy
Abstract:Diabetes is a complex chronic condition that affects the body's ability to produce or use insulin effectively, resulting in elevated blood glucose levels. It is associated with various complications and comorbidities, significantly impacting both individuals and the health care system. Effective management involves a combination of lifestyle adjustments, medication adherence, monitoring, education, and support. The expanding use of continuous glucose monitoring (CGM) has been transformative in diabetes care, providing valuable real-time data and insights for better management. To understand the opportunity for health plans to support improved patient outcomes with CGM, AMCP sponsored a multifaceted approach to identify best practices consisting of expert interviews, a national payer survey, an expert panel workshop with clinical experts and managed care stakeholders, and a national webcast to communicate the program findings. This article summarizes current evidence for CGM to support managed care and payer professionals in making collaborative, evidence-based decisions to optimize outcomes among patients with diabetes. In addition, this review also presents the findings of a national payer survey and describes expert-supported health plan best practices around coverage and access to CGM.
pharmacology & pharmacy,health care sciences & services
What problem does this paper attempt to address?